Send to

Choose Destination
JAMA Intern Med. 2019 Jan 22. doi: 10.1001/jamainternmed.2018.8121. [Epub ahead of print]

Physicians' Perspectives on FDA Approval Standards and Off-Label Drug Marketing.

Author information

Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
The Center for Medicine and the Media, Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire.
The American Board of Internal Medicine, Philadelphia, Pennsylvania.

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center